Rankings
▼
Calendar
SRPT (Sarepta Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$2.2B
Net Income (TTM)
-$713M
EPS (TTM)
-$8.44
Free Cash Flow (TTM)
-$317M
Gross Margin
59.9%
Op. Margin
-29.9%
Net Margin
-32.5%
FCF Margin
-14.4%
P/S Ratio (TTM)
0.9x
P/E Ratio (TTM)
—
YoY Rev Growth
+15.6%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$254M
$218M
-$138M
Q2 23
$261M
$227M
-$134M
Q3 23
$332M
$295M
-$21M
Q4 23
$397M
$353M
$25M
Q1 24
$413M
$363M
$35M
Q2 24
$363M
$318M
-$701K
Q3 24
$467M
$375M
$22M
Q4 24
$658M
$526M
$162M
Q1 25
$745M
$607M
-$300M
Q2 25
$611M
$459M
$116M
Q3 25
$399M
$249M
-$103M
Q4 25
$443M
$2M
-$370M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.9x
—
Q2 23
1.9x
—
Q3 23
1.7x
—
Q4 23
1.5x
—
Q1 24
1.3x
112.0x
Q2 24
1.3x
40.0x
Q3 24
1.2x
15.5x
Q4 24
1.0x
8.0x
Q1 25
0.8x
—
Q2 25
0.8x
—
Q3 25
0.8x
—
Q4 25
0.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$209M
-$219M
Q2 23
-$122M
-$140M
Q3 23
-$115M
-$155M
Q4 23
-$55M
-$74M
Q1 24
-$242M
-$285M
Q2 24
$15M
-$14M
Q3 24
-$71M
-$108M
Q4 24
$92M
$54M
Q1 25
-$583M
-$629M
Q2 25
$261M
$229M
Q3 25
-$15M
-$43M
Q4 25
$131M
$125M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$10M
Q2 23
$18M
Q3 23
$41M
Q4 23
$19M
Q1 24
$42M
Q2 24
$29M
Q3 24
$37M
Q4 24
$38M
Q1 25
$46M
Q2 25
$32M
Q3 25
$28M
Q4 25
$6M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+20.2%
+31.5%
Q2 23
+11.9%
-11.2%
Q3 23
+44.1%
-2.5%
Q4 23
+53.5%
+1.9%
Q1 24
+63.1%
-3.3%
Q2 24
+38.9%
-7.9%
Q3 24
+40.8%
+26.2%
Q4 24
+65.9%
+33.5%
Q1 25
+80.2%
+176.1%
Q2 25
+68.4%
+36.3%
Q3 25
-14.5%
+13.0%
Q4 25
-32.7%
+63.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$41M
16.3%
Q2 23
$47M
18.1%
Q3 23
$48M
14.5%
Q4 23
$46M
11.5%
Q1 24
$41M
9.8%
Q2 24
$50M
13.9%
Q3 24
$43M
9.3%
Q4 24
$50M
7.5%
Q1 25
$41M
5.6%
Q2 25
$37M
6.1%
Q3 25
$15M
3.7%
Q4 25
$30M
6.8%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$246M
$111M
Q2 23
$242M
$119M
Q3 23
$194M
$121M
Q4 23
$196M
$132M
Q1 24
$200M
$127M
Q2 24
$180M
$139M
Q3 24
$224M
$128M
Q4 24
$200M
$164M
Q1 25
$773M
$134M
Q2 25
$204M
$138M
Q3 25
$219M
$92M
Q4 25
$325M
$116M
marketcaparena.com
Revenue by Geography
Rest of World
United States
Quarter
Rest of World
United States
Q1 25
$375M
$375M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$872M
$1.0B
$1.9B
Q2 23
$852M
$1.0B
$1.9B
Q3 23
$542M
$1.2B
$1.7B
Q4 23
$428M
$1.2B
$1.7B
Q1 24
$427M
$963M
$1.4B
Q2 24
$384M
$1.1B
$1.5B
Q3 24
$198M
$1.0B
$1.2B
Q4 24
$1.1B
$252M
$1.4B
Q1 25
$241M
$282M
$523M
Q2 25
$511M
$290M
$800M
Q3 25
$613M
$238M
$851M
Q4 25
$801M
$138M
$940M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
88M
+0.4%
Q2 23
89M
+0.6%
Q3 23
89M
+0.2%
Q4 23
106M
+18.8%
Q1 24
99M
-6.1%
Q2 24
99M
+0.0%
Q3 24
100M
+1.3%
Q4 24
108M
+8.0%
Q1 25
97M
-10.2%
Q2 25
107M
+9.5%
Q3 25
100M
-6.0%
Q4 25
105M
+4.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$48K
204
FY 15
$5K
270
FY 16
$28K
197
FY 17
$606K
255
FY 18
$603K
499
FY 19
$513K
743
FY 20
$624K
866
FY 21
$836K
840
FY 22
$803K
1K
FY 23
$946K
1K
FY 24
$1M
1K
FY 25
$11K
200K
marketcaparena.com